Anvari, S., Watkin, L. B., Minard, C. G., Schuster, K., Hassan, O., Anagnostou, A., Orange, J. S., Corry, D. B., & Davis, C. M. (2022). Reduced pro-inflammatory dendritic cell phenotypes are a potential indicator of successful peanut oral immunotherapy. PLOS ONE, 17(5), e0264674. https://doi.org/10.1371/journal.pone.0264674

Davis, C. M., Anagnostou, A., Devaraj, S., Vita, D. T., Rivera, F., Pitts, K., Hearrell, M., Minard, C., Guffey, D., Gupta, M., Watkin, L., Orange, J. S., & Anvari, S. (2022). Maximum Dose Food Challenges Reveal Transient Sustained Unresponsiveness in Peanut Oral Immunotherapy (POIMD Study). The Journal of Allergy and Clinical Immunology: In Practice, 10(2), 566-576.e6. https://doi.org/10.1016/j.jaip.2021.10.074